Start exploring your own markets for free

🚀 Try for Free

Companies Attending VIVE Event 2025

Deep Dive running
Invite
Radar Tracking
Enhance your Space with Subspaces:By adding Subspaces, you help the AI to better understand and cater to your preferences.

Pending to review

Not sure yet

Interested

Not interested

Download list

Showing 4828 results
Company
Relevance
Description
Subspaces
Tags
HQ Location
Founding Date
Employees
Total Funding Raised
Last Funding Event
Received on
Generated Health is a healthcare application developer focused on collating patient information through blood work and health monitoring. The company provides assistance to individuals dealing with conditions like asthma, COPD, diabetes, heart failure, hypertension, lifestyle exercise, maternity, medical reminders, mental health, and pain management.
New
West Chester (United States)200911 - 50$1.57MSeed, $1.03M, July 16, 2024
Jan 28, 2025
Generator Ventures is an investment platform focused exclusively at the intersection of aging, senior care & technology. We partner with exceptional entrepreneurs who are leveraging technology to transform the aging experience.
New
Redwood City (United States)20141 - 10NA
Jan 28, 2025
Our goal at Genesis Orthopedics & Sports Medicine is simple: free our patients to be more active, more athletic, and to move freely in their bodies – accessible to everyone, not just the select few. That our patients, regardless of walk of life, move more freely, function better, and experience life to the full. We accept all public insurance as well as the uninsured.
New
Saint Charles (United States)20001 - 10NA
Jan 28, 2025
Provider of genetic testing services intended for patients seeking to understand their genetic risks and identify any genetic mutations that may cause diseases. The company analyzes a patient's DNA to identify potential risks for a variety of diseases, allowing patients to make informed decisions about their healthcare.
New
Nashville (United States)201911 - 50NA
Jan 28, 2025
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs.
New
Copenhagen (Denmark)1999501 - 1000$204.30MPost-IPO Equity, $134.00M, July 1, 2010
Jan 28, 2025
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.
With Momentum
New
South San Francisco (United States)201651 - 200$195.74MVenture - Series Unknown, $75.34M, September 23, 2024
Jan 28, 2025
Genomic Life provides genomic products to policyholders and employees around the world through trusted employee benefit brokers. It is helping transform medicine and healthcare by making genomic medicine and proactive health a reality for everyone.
New
San Diego (United States)201751 - 200$10.00MVenture - Series Unknown, $10.00M, May 7, 2024
Jan 28, 2025
Developer of a genomics risk assessment platform designed to help physicians integrate genomic-based personalized medicine. The company's assessments are supported by substantial, peer-reviewed research and offer population-based screening with individualized relative risk scoring where a small percentage of patients provide their family history, and traditional monogenic mutations, enabling physicians to understand genomic risks for diseases such as cancer, diabetes, and cardiovascular conditions and people to take proactive measures to lead healthier lives by providing individualized, clinical risk assessments
New
Chicago (United States)202311 - 50NA
Jan 28, 2025
Operator of a mental health biotechnology company intended to provide personalized mental healthcare and wellness through genetic testing. The company provides a prescription pharmacogenetic test that equips mental health professionals with the tools they need to identify a personalized treatment plan for their patients and offers comprehensive genetic guidance and accurate state-of-the-art digital tools, enabling clinicians to help diagnose or treat psychiatric illnesses.
New
Chalfont (United States)200951 - 200$73.98MVenture - Series Unknown, $20.58M, September 17, 2020
Jan 28, 2025
Genpact is a business process management and IT services company that helps clients enhance operations through processes, analytics, and technology. The company serves industries like banking, insurance, retail, life sciences, and healthcare, offering services such as finance and accounting, analytics, IT management, supply chain, and procurement. Genpact operates across multiple sectors to drive business efficiency and intelligence.
New
New York (United States)1997+10000$400.00MPost-IPO Debt, $400.00M, May 30, 2024
Jan 28, 2025